After a multi-year strategy, we succeeded in making dental amalgam a  major focus of the U.S. Food and Drug Administration. FDA's recommendations  against amalgam use for children; most women of childbearing age; and people  with kidney impairments, neurological disease, and mercury hypersensitivities –  a broad swath of Americans – are a gigantic step in the right direction.   We even got infographics to help further  spread the word. Now we need to make sure this critical information is  getting into the hands of the people who need it most: patients.
Here's our opportunity!  FDA is now asking: "How should materials  information about medical devices be conveyed to patients and healthcare  providers?" 
Please click  here* to submit a comment to FDA by the 18 August deadline.  When writing  your comment, please consider addressing the following points that can be  personalized to make an even bigger impact:
    - It is important to get FDA's       recommendations against amalgam use into the hands of patients because…… (for example: I/my family member/my friend was not       told about amalgam's mercury, we would have       chosen mercury-free fillings if we had more information,       the American Dental Association is ignoring FDA's recommendations,       etc.)
 
    - Information about amalgam that       patients need beyond what is included in FDA's recommendations includes...... (for example: how mercury is not safe for       anybody, how to safely dispose of amalgam fillings and amalgam-filled       teeth that fall out at home, how amalgam's mercury also poses a higher       risk to people already exposed to mercury at work or in their diets,       etc.)
 
    - Effective ways to get FDA's       recommendations against amalgam use into the hands of patients would       include...... (for example: a consent       form requiring patient signature, a checklist of talking points       dentists should discuss with patients, guidance for amalgam       manufacturers telling them to include patient labeling, etc.)
 
If the amalgam issue draws the most responses to the question of how  best to convey information to patients, our momentum continues!  After  all, government policies like FDA's recommendations against amalgam use –  however good the intentions – do not implement themselves. It takes citizens  like you speaking out to make sure that they are put in action. 
* https://www.regulations.gov/commenton/FDA-2021-N-0334-0002